SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001654954-20-007995
Filing Date
2020-07-24
Accepted
2020-07-24 16:30:35
Documents
5
Period of Report
2020-07-24

Document Format Files

Seq Description Document Type Size
1 PRE 14A azrx_pre14ajuly2020.htm PRE 14A 825272
2 IMAGE azurrx.jpg GRAPHIC 5741
3 IMAGE votebyinternet.jpg GRAPHIC 1540
4 IMAGE votebymail.jpg GRAPHIC 1539
5 IMAGE votebyphone.jpg GRAPHIC 1627
  Complete submission text file 0001654954-20-007995.txt   841349
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37853 | Film No.: 201047217
SIC: 2834 Pharmaceutical Preparations